Merck & Company Inc (MRK BE) stock market data APIs
€109.1953
1.94(1.8%)
as of March 18, 2026
Try our APIs with
free plan!
Merck & Company Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for MRK.BE.
Prev. Close
109.1953
Open
111.1318
High
112.9866
Low
107.6868
52 wk Range
104-127.9062
Market Cap
97 608 M
Dividends (Yield)
0.0134
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Merck & Company Inc data using free add-ons & libraries
Get Merck & Company Inc Fundamental Data
Merck & Company Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-05
- EPS/Forecast: 1.94
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Merck & Company Inc News
New
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Recursion Pharmaceuticals RXRX reported a loss of 21 cents per share in the fourth quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of 28 cents. The company had incurred a loss of...
Sanofi’s (SNY) R&D Track Record Remains Investor Concern, Says BofA
Sanofi (NASDAQ:SNY) is among the 7 Oversold Pharma Stocks to Buy Now.Sanofi's (SNY) R&D Track Record Remains Investor Concern, Says BofA Sanofi (NASDAQ:SNY) is one of the most oversold stocks. TheFl...
Sanofi Names Belén Garijo CEO As Investors Eye R&D And Valuation
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Sanofi (ENXTPA:SAN) has appointed Belén Garijo as its ne...
Is Merck KGaA (XTRA:MRK) Share Price Misaligned With Cash Flow And Earnings Valuation Estimates
If you are wondering whether Merck KGaA is offering fair value at its current share price, this article will walk you through what the numbers are really saying. The stock last closed at €128.75, wi...
Get Merck & Company Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
